Competition & Peer Data API & CSV Delivery

Pacs Group Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Pacs Group Inc (PACS) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
9.07 %
Q2 2026
Net Margin
5.35 %
Q2 2026

Key Findings: Pacs Group Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 5,551M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+2.9% annualized vs trailing 12 months).
  • Scale: Pacs Group Inc ranks #9 of 51 companies by market capitalization in the Healthcare Facilities industry, holding 2.7% of industry market cap.
  • Peer revenue share: Pacs Group Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

PACS Sales vs. its Competitors, Q2 2026

Pacs Group Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/PACS/competitors
https://api.csimarket.com/api/v1/companies/PACS/relationships
https://api.csimarket.com/api/v1/companies/PACS/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Healthcare Facilities industry grew revenue 14.7% year over year, combined, vs 9.1% for Pacs Group Inc. Pacs Group Inc's share of combined industry revenue moved from 1.27% to 1.21%, a loss of 0.06 percentage points.

Pacs Group Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Pacs Group Inc Yes Yes Yes Yes
Similar-Size Competitors (10) 90% 100% 90% 10%
Similar Growth & Profitability (8) 100.00 % (8 of 8) 100.00 % (8 of 8) 100.00 % (8 of 8) 14.30 % (1 of 7)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q2 2026

100%market share
  • Pacs Group Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Pacs Group Inc and its 0 tracked competitors.

See Pacs Group Inc's full market share breakdown »

PACS Stock Performance relative to its Competitors

PACS Competitors (weighted) Percent change over the selected range

Pacs Group Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
40%beat U.S.A. 500
Similar-Size
(4 of 10)
28.6%beat U.S.A. 500
Similar Growth & Profitability
(2 of 7)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Pacs Group Inc 233.70 % Outperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (0) 40.4% 63.2%
Similar-Size Competitors (10) 40.4% 63.2%
Similar Growth & Profitability (7) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Pacs Group Inc's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

PACS Stock Performance relative to Similar-Size Competitors

PACS Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

PACS Stock Performance relative to Similar Growth & Profitability Competitors

PACS Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Pacs Group Inc's Comment on Competition and Industry Peers

The post-acute care industry is characterized by significant competition and fragmentation, involving numerous local and regional providers alongside large national organizations with geographic diversity and economies of scale. Independently operated facilities compete with inpatient rehabilitation facilities, long-term acute care hospitals, and an increasing number of home health and community-based providers delivering services outside of facility-based settings. Competitive dynamics vary by location, influenced by factors such as the number of competing facilities, availability of services, staff expertise, and facility amenities. Key competitive factors include the ability to attract and retain qualified management and clinicians, reputation and quality of healthcare outcomes, facility attractiveness and location, and pricing competitiveness.

Pacs Group Inc's Business Segment Mix vs Peers

Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).
Company Largest Segment 2nd Segment 3rd Segment
Pacs Group Inc Reportable 100.00 % - -

Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).